Masaryk University
This project aims to monitor the side effects of COVID-19 vaccines worldwide actively. The primary objectives of the project include a) to estimate the prevalence of each local and systemic side effect of each COVID-19 vaccine among healthcare workers (HCW), old adults over +65 (OA), and schoolteachers (ST); b) to evaluate the potential demographic and medical risk factors for side effects frequency and intensity; c) to evaluate the long-term consequences of COVID-19 vaccines. The secondary objectives include a) to evaluate the relative safety of COVID-19 vaccines compared to each other; b) to evaluate the impact of palliative drugs used by the recently vaccinated individuals on their short-term side effects resolution.
Introduction: COVID-19 vaccines are the foremost asset to overcome the ongoing pandemic; therefore, mass vaccination has become a high priority for the world's governments. While vaccination strategies need to be accelerated to minimise daily fatalities and relieve the pandemic's economic burdens, vaccine hesitancy (VH) remains a serious challenge for these efforts. VH refers to "delay in acceptance or refusal of vaccines despite availability of vaccine services",; and it is an emerging public health challenge nourished by misinformation related to vaccines effectiveness and safety. Aversion…
Inclusion Criteria: * HCW, OA and ST who received COVID-19 vaccine. * Participating subjects should be at least 18-year-old and able to give their informed consent independently. Exclusion Criteria: * Non HCW, OA and ST who received the COVID-19.
Receiving either the first dose only or both doses of BNT162b2 vaccine (Pfizer-BioNTech COVID-19 Vaccine)
Receiving either the first dose only or both doses of mRNA-1273 vaccine (Moderna COVID-19 Vaccine)
Receiving either the first dose only or both doses of AZD1222 vaccine (AstraZeneca-Oxford University COVID-19 Vaccine)
Receiving either the first dose only or both doses of CoronaVac (Sinovac COVID-19 Vaccine)
Receiving either the first dose only or both doses of Sinopharm Vero Cell COVID-19 Vaccine
Receiving either the first dose only or both doses of Gam-COVID-Vac (Sputnik V)
Receiving JNJ-78436735 (Janssen COVID-19 Vaccine)
Receiving either the first dose only or both doses of CVnCoV (CureVac COVID-19 vaccine)
Receiving either the first dose only or both doses of NVX-CoV2373 (Novavax COVID-19 vaccine)
Receiving either the first dose only or both doses of BBV152 (Covaxin COVID-19 vaccine)